BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 38350488)

  • 1. The molecular mechanisms underlying gut microbiota-miRNA interaction in metabolic disorders.
    Prukpitikul P; Sirivarasai J; Sutjarit N
    Benef Microbes; 2024 Jan; 15(1):83-96. PubMed ID: 38350488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Regulate Intestinal Immunity and Gut Microbiota for Gastrointestinal Health: A Comprehensive Review.
    Bi K; Zhang X; Chen W; Diao H
    Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32932716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MicroRNA regulation on host-microbiota interaction--a review].
    Mu C; Zhu W
    Wei Sheng Wu Xue Bao; 2013 Oct; 53(10):1018-24. PubMed ID: 24409756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the gut microbiota in type 2 diabetes and related diseases.
    Yang G; Wei J; Liu P; Zhang Q; Tian Y; Hou G; Meng L; Xin Y; Jiang X
    Metabolism; 2021 Apr; 117():154712. PubMed ID: 33497712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics.
    Casado-Bedmar M; Viennois E
    J Crohns Colitis; 2022 Jul; 16(6):992-1005. PubMed ID: 34918052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal microRNAs and bacterial taxa in juvenile mice are associated, modifiable by allochthonous lactobacilli, and affect postnatal maturation.
    Taibi A; Tokar T; Tremblay J; Gargari G; Streutker CJ; Li B; Pierro A; Guglielmetti S; Tompkins TA; Jurisica I; Comelli EM
    mSystems; 2023 Aug; 8(4):e0043123. PubMed ID: 37462361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.
    Serino M
    J Mol Biol; 2018 Mar; 430(5):581-590. PubMed ID: 29374557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Gut Microbiota on Intestinal Immunity Mediated by Tryptophan Metabolism.
    Gao J; Xu K; Liu H; Liu G; Bai M; Peng C; Li T; Yin Y
    Front Cell Infect Microbiol; 2018; 8():13. PubMed ID: 29468141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating host gene expression via gut microbiome-microRNA interplay to treat human diseases.
    Mody D; Verma V; Rani V
    Crit Rev Microbiol; 2021 Sep; 47(5):596-611. PubMed ID: 34407384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and immune crosstalk in metabolic disease].
    Burcelin R
    Biol Aujourdhui; 2017; 211(1):1-18. PubMed ID: 28682223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between hepatic miRNA expression, liver triacylglycerols and gut microbiota during metabolic adaptation to high-fat diet in mice.
    Blasco-Baque V; Coupé B; Fabre A; Handgraaf S; Gourdy P; Arnal JF; Courtney M; Schuster-Klein C; Guardiola B; Tercé F; Burcelin R; Serino M
    Diabetologia; 2017 Apr; 60(4):690-700. PubMed ID: 28105518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Composition of gut microbiota and its correlations with neurological, intestinal, cardiovascular and metabolic diseases.
    Sciuto M; Catanzaro R
    Acta Microbiol Immunol Hung; 2023 Dec; 70(4):259-271. PubMed ID: 37938237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Milk Replacer-Based
    Wang Y; An M; Zhang Z; Zhang W; Kulyar MF; Iqbal M; He Y; Li F; An T; Li H; Luo X; Yang S; Li J
    Microbiol Spectr; 2022 Aug; 10(4):e0115522. PubMed ID: 35771011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain.
    Deng Y; Zhou M; Wang J; Yao J; Yu J; Liu W; Wu L; Wang J; Gao R
    Gut Microbes; 2021; 13(1):1-16. PubMed ID: 33535879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of the gut microbiota-miRNA interaction in the host pathophysiology.
    Li M; Chen WD; Wang YD
    Mol Med; 2020 Nov; 26(1):101. PubMed ID: 33160314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbial-mammalian metabolic axis: a critical symbiotic relationship.
    Chilloux J; Neves AL; Boulangé CL; Dumas ME
    Curr Opin Clin Nutr Metab Care; 2016 Jul; 19(4):250-256. PubMed ID: 27137897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptophan Dietary Impacts Gut Barrier and Metabolic Diseases.
    Taleb S
    Front Immunol; 2019; 10():2113. PubMed ID: 31552046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota bridges the iron homeostasis and host health.
    Xiao L; Tang R; Wang J; Wan D; Yin Y; Xie L
    Sci China Life Sci; 2023 Sep; 66(9):1952-1975. PubMed ID: 37515687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.